MedTrace Logo

Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy

NCT03742544 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-11-15

No results posted yet for this study

Summary

Post-marketing surveillance of Telostop TAB (Telmisartan/Rosuvastatin)

Conditions

Sponsors & Collaborators

  • IlDong Pharmaceutical Co Ltd

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-23
Primary Completion
2020-10-30
Completion
2020-10-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03742544 on ClinicalTrials.gov